Daptomycin high-yield engineering strain with high capric acid tolerance as well as construction and application of daptomycin high-yield engineering strain
By modifying the DptE protein and knocking out the TagR gene, a high yield engineering strain of daptomycin with high decanoic acid tolerance was constructed, which solved the problem of low utilization rate of decanoic acid precursors in daptomycin production, and achieved yield improvement and cost Reduced, providing solutions for industrial applications.
Patent Information
- Application Number
- CN202411356985.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-07-29
- Filing Date
- 2024-09-27
- Publication Date
- 2024-11-12
AI Technical Summary
The industrial production of daptomycin is limited by the high cytotoxicity and low utilization of the direct precursor of the biosynthesis of capric acid, which makes it difficult to increase yields.
By modifying the DptE protein of daptomycin biosynthesis and knocking out the negative regulatory factor TagR-encoded gene, a high-decanogenic engineering strain with high decanoic acid tolerance was constructed, and the utilization rate of the strain for decanoic acid precursor was improved. and yield.
It significantly improves the yield of daptomycin and the tolerance of the strain to capric acid, reduces production costs, and provides stable and reliable engineering strains for industrial production, which has important application value.
Smart Images

Figure CN118931855A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of pharmaceutical biotechnology, and in particular to a daptomycin high-yield engineering strain with high decanoic acid tolerance and a construction and application thereof. Background Art
[0002] Daptomycin is a new lipopeptide antibiotic for the treatment of drug-resistant Gram-positive bacterial infections. It was first approved for marketing by the U.S. FDA in 2003 and is produced by Cubist. It is mainly used to treat severe infections caused by multidrug-resistant bacteria, has a broad spectrum of anti-Gram-positive bacterial activity, and is widely used in clinical practice.
[0003] Lipopeptide antibiotics are usually obtained by microbial fermentation and purification in industry. Fatty acid precursors (such as decanoic acid) are the starting biosynthetic elements of lipopeptide antibiotics, and ultimately form the highly biologically active fatty acid tail chains of lipopeptide antibiotics. Therefore, fatty acid precursors are crucial for the biosynthesis of lipopeptide antibiotics and the development of their pharmaceutical activity. However, the high toxicity and low utilization rate of fatty acid precursors limit the development of high-yield strategies for lipopeptide antibiotics. As an important member of the lipopeptide antibiotic family, the industrial production of daptomycin is also limited by the high cytotoxicity and low utilization rate of decanoic acid, the direct precursor of biosynthesis. It has always been difficult to increase the yield by increasing the concentration of the direct precursor. Summary of the invention
[0004] In view of the deficiency of low tolerance of daptomycin production strains to fatty acid precursors in the prior art, the present invention provides a high-capric acid-tolerant daptomycin high-yield engineered strain and its construction and application. The present invention improves the utilization rate of decanoic acid precursors of the engineered strain by modifying the daptomycin biosynthesis initiation protein (DptE protein) and knocking out the negative regulatory factor TagR encoding gene, significantly increases the daptomycin yield of the engineered strain, and has better capric acid tolerance.
[0005] The technical solution adopted by the present invention is as follows:
[0006] (I) A DptE mutant protein
[0007] The DptE mutant protein includes one of the DptE mutant protein DptE::K454I, the DptE mutant protein DptE::K454R and the DptE mutant protein DptE::K454I::Q420N::K184Q.
[0008] Among them, the DptE mutant protein DptE::K454I is obtained by the mutation of lysine at position 454 of the DptE protein to isoleucine; the DptE mutant protein DptE::K454R is obtained by the mutation of lysine at position 454 of the DptE protein to arginine; the DptE mutant protein DptE::K454I::Q420N::K184Q is obtained by the mutation of lysine at position 454 of the DptE protein to isoleucine, glutamine at position 420 to asparagine and lysine at position 184 to glutamine.
[0009] Among them, the amino acid sequence of the DptE protein is shown in SEQ ID NO.2; the amino acid sequence of the DptE mutant protein DptE::K454I is shown in SEQ ID NO.4; the amino acid sequence of the DptE mutant protein DptE::K454R is shown in SEQ ID NO.6; the amino acid sequence of the DptE mutant protein DptE::K454I::Q420N::K184Q is shown in SEQ ID NO.8.
[0010] (II) A DptE mutant protein encoding gene for encoding a DptE mutant protein
[0011] The DptE mutant protein encoding gene includes one of the DptE mutant protein encoding gene K454I, the DptE mutant protein encoding gene K454R, and the DptE mutant protein encoding gene K454I::Q420N::K184Q.
[0012] Among them, the DptE mutant protein encoding gene K454I is used to encode the DptE mutant protein DptE::K454I, and the base sequence is shown in SEQ ID NO.3; the DptE mutant protein encoding gene K454R is used to encode the DptE mutant protein DptE::K454R, and the base sequence is shown in SEQ ID NO.5; the DptE mutant protein encoding gene K454I::Q420N::K184Q is used to encode the DptE mutant protein DptE::K454I::Q420N::K184Q, and the base sequence is shown in SEQID NO.7.
[0013] (III) An engineered strain
[0014] The engineering strain is Streptomyces roseosporus, with a collection number of CGMCC4.7231, as a starting strain. The engineering strain is obtained by replacing the DptE protein encoding gene in the starting strain with the above-mentioned DptE mutant protein encoding gene, and knocking out the bacterial negative regulatory factor TagR protein encoding gene.
[0015] Wherein, the base sequence of the DptE protein encoding gene is shown as SEQ ID NO.1.
[0016] The base sequence of the TagR protein encoding gene is shown in SEQ ID NO. 9. The TagR protein encoding gene expresses TagR protein, the amino acid sequence of the TagR protein is shown in SEQ ID NO. 10, and the TagR protein is a negative regulatory factor of the teichoic acid transferase system.
[0017] Preferably, the engineered strain (Streptomyces roseosporus) delta-tagR::DptE3M is constructed by replacing the DptE protein encoding gene in the starting strain with the DptE mutant protein encoding gene K454I::Q420N::K184Q, and knocking out the TagR protein encoding gene. The present invention constructs an engineered strain: Streptomyces roseosporus delta-tagR::DptE3M through this preferred scheme. The classification name of the engineered strain is Streptomyces roseosporus delta-tagR::DptE3M, and the depository unit is the General Microbiology Center of the China Microbiological Culture Collection Administration, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, the deposit number is CGMCCNO.31146, and the deposit date is July 2, 2024.
[0018] (IV) A method for constructing an engineered strain
[0019] The construction method comprises the following steps:
[0020] S1) using the genome of Streptomyces roseosporus as a template, amplifying the upstream homology arm and the downstream homology arm of the DptE protein encoding gene, and constructing the upstream homology arm and the downstream homology arm of the DptE protein encoding gene into the knockout vector pKC1139 to obtain the dptE gene knockout plasmid pKC1139-dptE-Knock-out;
[0021] Using E. coli ET12567 / pUZ8002-mediated E. coli-Streptomyces interspecies transfer technology, the dptE gene knockout plasmid pKC1139-dptE-Knock-out was introduced into the wild-type Streptomyces roseosporus to obtain the dptE-deficient Streptomyces roseosporus ΔdptE.
[0022] S2) using the genome of Streptomyces roseosporus as a template, amplifying a DptE protein encoding gene fragment, using the DptE protein encoding gene fragment as a template, introducing amino acid mutations using PCR technology to obtain a DptE mutant protein encoding gene fragment, and inserting the DptE mutant protein encoding gene fragment into the expression vector pSET152 to obtain a dptE mutant plasmid;
[0023] Using the E. coli-Streptomyces interspecies transfer technique mediated by E. coli ET12567 / pUZ8002, the dptE mutant plasmid was introduced into the dptE-deficient Streptomyces roseosporus ΔdptE to obtain the dptE mutant Streptomyces roseosporus;
[0024] In the step S2), the base sequence of the DptE protein encoding gene fragment is shown as SEQ ID NO.1; the base sequence of the DptE mutant protein encoding gene fragment is shown as SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7.
[0025] S3) using the genome of Streptomyces roseosporus as a template, amplifying the upstream homology arm and the downstream homology arm of the TagR protein encoding gene, and constructing the upstream homology arm and the downstream homology arm of the TagR protein encoding gene into the knockout vector pKC1139 to obtain the tagR gene knockout plasmid pKC1139-ΔtagR;
[0026] Using E. coli ET12567 / pUZ8002-mediated E. coli-Streptomyces interspecies transfer technology, the tagR gene knockout plasmid pKC1139-ΔtagR was introduced into the dptE mutant Streptomyces roseosporus to obtain the engineered strain;
[0027] In the step S3), the base sequence of the TagR protein encoding gene is shown as SEQ ID NO.9.
[0028] (V) Application of a DptE mutant protein and its encoding gene, and daptomycin high-yield engineered strain
[0029] The above-mentioned DptE mutant protein, DptE mutant protein encoding gene, and daptomycin high-yield engineered strain can all be used for fermentation production of daptomycin.
[0030] (VI) A method for producing daptomycin
[0031] The method for producing daptomycin comprises the following steps: using a fermentation medium to cultivate a daptomycin high-yield engineered strain, after culturing for 70 hours to 74 hours, dripping a capric acid mixture into the fermentation medium at a volume ratio of 1‰ to 4‰ (i.e., the volume of the capric acid mixture: the volume of the fermentation medium = 1 to 4: 1000) every 12 hours, obtaining a fermentation product after the cultivation is completed, and separating fidaxomicin from the fermentation product.
[0032] The present invention discovers and rationally transforms the protein according to the crotonylation modification site (lysine 454) of the daptomycin biosynthesis protein DptE by mining the post-crotonylation modification group of the rose spore Streptomyces protein. The DptE protein can connect AMP to the terminal carboxyl of the toxic precursor decanoic acid, and the activated decanoyl group can be further presented to the daptomycin NRPS synthase by the downstream DptF protein, thereby opening the daptomycin biosynthesis. Therefore, DptE is the key starting protein and important rate-limiting enzyme in the daptomycin biosynthesis process, and indirectly protects the bacterium by consuming toxic decanoic acid. The present invention improves the activity of DptE protein in catalyzing decanoic acid into decanoyl AMP by protein engineering means, increases the utilization efficiency of decanoic acid in the bacterium, and significantly improves the daptomycin yield of the strain. TagR protein is a negative regulatory factor screened based on the DNA methylation modification group of rose spore Streptomyces, which is responsible for regulating the teichoic acid ABC transport system and is closely related to the environmental stress response of the bacterium. The present invention further increases the tolerance of the bacterium to the toxic precursor decanoic acid by knocking out the TagR protein encoding gene, thereby significantly reducing the production cost of daptomycin.
[0033] The beneficial effects of the present invention are:
[0034] 1. The DptE mutant protein and its encoding gene provided by the present invention can increase the daptomycin production of the host bacteria and improve the tolerance of the host bacteria to decanoic acid precursors.
[0035] 2. The daptomycin high-yield engineered strain with high decanoic acid tolerance provided by the present invention has a daptomycin yield significantly increased by 132% compared with the strain without DptE protein mutation. The strain has significantly improved tolerance to the toxic precursor decanoic acid, providing a strong guarantee for the utilization of raw materials and strain stability in the industrial fermentation process, and is conducive to further improving the daptomycin yield through downstream technical means such as decanoic acid fed-batch process development in industrial production.
[0036] 3. The method of the present invention avoids the shortcomings of the traditional mutagenesis breeding, such as long cycle and large consumption of manpower and material resources, and greatly reduces the production cost of daptomycin, and has important application value in the industrial production process.
[0037] 4. The method for constructing the engineered strain provided by the present invention can not only provide a stable and reliable engineered strain for the industrial fermentation production of daptomycin, but also has inspiring significance and clear application value for the development of high-yield strategies for lipopeptide antibiotics. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 This is a comparison chart of the residual decanoic acid in the dptE mutant Streptomyces roseosporus in Example 2 of the present invention;
[0039] Figure 2 This is a comparison chart of daptomycin production of dptE mutant Streptomyces roseosporus in Example 2 of the present invention;
[0040] Figure 3 This is a growth curve comparison diagram of the engineered strain of Streptomyces roseosporus in Example 3 of the present invention;
[0041] Figure 4 is the protein spectrum of the DptE protein in the present invention;
[0042] Figure 5 This is a comparison chart of daptomycin production of dptE mutant Streptomyces roseosporus in Example 1 of the present invention. DETAILED DESCRIPTION
[0043] The present invention will be further described below in conjunction with the accompanying drawings and embodiments.
[0044] The present invention provides a method for constructing a daptomycin high-yield engineered strain with high decanoic acid tolerance. The construction method specifically comprises the following steps:
[0045] S1) The DptE protein encoding gene (dptE gene) is knocked out from the wild-type Streptomyces roseosporus (CGMCC 4.7231) to construct a dptE-deficient Streptomyces roseosporus ΔdptE. The base sequence of the DptE protein encoding gene is shown in SEQ ID NO.1. The specific steps are as follows:
[0046] S1.1) using the genome of Streptomyces roseosporus as a template, using an upstream homology arm amplification primer pair and a downstream homology arm amplification primer pair of the DptE protein encoding gene to amplify the upstream homology arm and the downstream homology arm of the DptE protein encoding gene, respectively, and recovering them to obtain the upstream homology arm and the downstream homology arm of the DptE protein encoding gene;
[0047] The upstream homology arm amplification primer pair of the DptE protein encoding gene includes a first dptE upstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.11 and a second dptE upstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.12; the downstream homology arm amplification primer pair of the DptE protein encoding gene includes a first dptE downstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.13 and a second dptE downstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.14.
[0048] S1.2) constructing the upstream homology arm and the downstream homology arm of the DptE protein encoding gene obtained in step S1.1) into the knockout vector pKC1139 to obtain the dptE gene knockout plasmid pKC1139-dptE-Knock-out and sequencing verification;
[0049] S1.3) The dptE gene knockout plasmid pKC1139-dptE-Knock-out obtained in step S1.2) is introduced into Escherichia coli ET12567 / pUZ8002 by transformation technology to obtain Escherichia coli ET12567 / pUZ8002 / pKC1139-ΔdptE;
[0050] S1.4) The E. coli ET12567 / pUZ8002 / pKC1139-ΔdptE obtained in step S1.3) was cultured in LB medium until OD 600 =0.6 and then mixed with Streptomyces roseosporus, and the dptE gene knockout plasmid pKC1139-dptE-Knock-out obtained in step S1.2) was transferred into Streptomyces roseosporus by conjugation transduction technology, and the dptE-deficient Streptomyces roseosporus ΔdptE with the DptE protein coding gene knocked out was obtained by screening.
[0051] S2) Introducing the DptE mutant protein encoding gene fragment into Streptomyces roseosporus ΔdptE to obtain dptE mutant Streptomyces roseosporus.
[0052] Wherein, the dptE mutant Streptomyces roseosporus is Streptomyces roseosporus ΔdptE::dptE::K454I expressing the DptE mutant protein DptE::K454I, Streptomyces roseosporus ΔdptE::dptE::K454R expressing the DptE mutant protein DptE::K454R, or Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q expressing the DptE mutant protein DptE::K454I::Q420N::K184Q. The specific steps are as follows:
[0053] S2.1) Design specific primers, use the genome of Streptomyces roseosporus as a template, amplify the DptE protein encoding gene and recover it to obtain the DptE protein encoding gene fragment. The base sequence of the DptE protein encoding gene is shown in SEQ ID NO.1;
[0054] S2.2) using the DptE protein encoding gene fragment as a template, using PCR technology to introduce amino acid mutations to obtain a DptE mutant protein encoding gene fragment, wherein the base sequence of the DptE mutant protein encoding gene fragment is shown in SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7;
[0055] S2.3) inserting the DptE mutant protein encoding gene fragment obtained in step S2.2) into the expression vector pSET152 to obtain a dptE mutant plasmid carrying the DptE mutant protein encoding gene fragment, and sequencing and verifying it;
[0056] S2.4) introducing the dptE mutant plasmid obtained in step S2.3) into E. coli E.coilET12567 / pUZ8002 by chemical transformation to obtain E. coli containing the dptE mutant plasmid;
[0057] S2.5) The Escherichia coli containing the dptE mutant plasmid is mixed with the dptE-deficient Streptomyces roseosporus ΔdptE, and then an Escherichia coli-Streptomyces interspecies transfer is performed, so that the dptE mutant plasmid is transferred into the dptE-deficient Streptomyces roseosporus ΔdptE, and a dptE mutant Streptomyces roseosporus carrying a gene fragment encoding a DptE mutant protein is obtained.
[0058] S3) knocking out the TagR protein encoding gene (tagR gene) from the dptE mutant Streptomyces roseosporus to construct an engineered strain. The base sequence of the TagR protein encoding gene is shown in SEQ ID NO.9, and the amino acid sequence of the TagR protein is shown in SEQ ID NO.10. The specific steps are as follows:
[0059] S3.1) using the genome of Streptomyces roseosporus as a template, using an upstream homology arm amplification primer pair and a downstream homology arm amplification primer pair of the TagR protein encoding gene to respectively amplify the upstream homology arm and the downstream homology arm of the TagR protein encoding gene and recover them to obtain the upstream homology arm and the downstream homology arm of the TagR protein encoding gene;
[0060] The upstream homology arm amplification primer pair of the TagR protein encoding gene includes a first tagR upstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.15 and a second tagR upstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.16; the downstream homology arm amplification primer pair of the TagR protein encoding gene includes a first tagR downstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.17 and a second tagR downstream homology arm amplification primer having a base sequence as shown in SEQ ID NO.18;
[0061] S3.2) constructing the upstream homology arm and the downstream homology arm of the TagR protein encoding gene obtained in step S3.1) into the knockout vector pKC1139 to obtain the tagR gene knockout plasmid pKC1139-ΔtagR and verifying it;
[0062] S3.3) introducing the tagR gene knockout plasmid pKC1139-ΔtagR obtained in step S3.2) into E. coli ET12567 / pUZ8002 by chemical transformation to obtain E. coli containing the tagR gene knockout plasmid pKC1139-ΔtagR;
[0063] S3.4) Escherichia coli containing the tagR gene knockout plasmid pKC1139-ΔtagR is mixed with the dptE mutant Streptomyces roseosporus, and then the Escherichia coli-Streptomyces interspecies transfer is performed to screen and obtain an engineered strain in which the TagR protein encoding gene is knocked out.
[0064] The specific embodiments of the present invention are as follows:
[0065] In the following description, the mutation type of the DptE mutant protein is named in the manner of "original amino acid-site number-amino acid after mutation", for example, K454I means that the 454th lysine (Lysine, abbreviated as K) of the DptE protein is mutated to isoleucine (I). Further, the DptE mutant protein is named in the manner of "DptE::mutation type", and when a DptE protein contains multiple mutation sites, these mutation sites will be connected in series according to the above format. For example, the DptE mutant protein DptE::K454I::Q420N::K184Q represents a DptE mutant protein obtained by mutation of K454I (mutating the 454th lysine of the DptE protein to isoleucine), Q420N (mutating the 420th glutamine of the DptE protein to asparagine) and K184Q (mutating the 184th lysine of the DptE protein to glutamine).
[0066] The experimental methods in the following examples are conventional methods unless otherwise specified. The plasmids, materials, reagents, etc. used in the following examples can be purchased from commercial sources unless otherwise specified. In the following examples, the Streptomyces roseosporus strain used has a deposit number of CGMCC 4.7231, which was obtained by commercial purchase.
[0067] The detailed formulas of the culture medium and reagents used in the embodiments of the present invention are as follows:
[0068] R5 solid culture medium: 22g / L agar, 0.1g / L casein hydrolysate, 0.25g / L potassium sulfate, 0.3g / L proline, 5g / L yeast extract, 5.73g / LTESbuffer powder, 10g / L glucose, 10.12g / L magnesium chloride hexahydrate, 103g / L sucrose and 0.2% trace element solution stock solution.
[0069] Trace element mother solution: 10 mg / L sodium borate decahydrate, 200 mg / L ferric chloride hexahydrate, 10 mg / L ammonium molybdate tetrahydrate, 10 mg / L manganese chloride, 10 mg / L copper chloride and 40 mg / L zinc chloride, add 1L distilled water to dissolve and set aside.
[0070] LB liquid medium: peptone 10.0 g, yeast extract 5.0 g, NaCl 10 g, agar 20.0 g and distilled water 1000 ml, pH 7.3.
[0071] Primary seed culture medium (TSB-MD): 30g / L TSB powder and 30g / L maltodextrin, add 1L water to dissolve.
[0072] Secondary seed culture medium (TSB): 20g / L TSB powder and 50g / L PEG6000 flakes, add 1L distilled water to dissolve.
[0073] Liquid fermentation medium (YEME): 3 g / L malt extract, 3 g / L yeast extract, 5 g / L tryptone and 40 g / L glucose, dissolved in 1 L distilled water.
[0074] Capric acid mixture: Capric acid and methyl oleate are mixed in a volume ratio of 1:1.
[0075] Example 1
[0076] In this example, saturation point mutation was performed on the post-crotonylation modification site K454 of the DptE protein to obtain multiple DptE point mutant proteins. Figure 4The protein spectrum in the results shows that the 454th lysine of DptE protein is crotonylated, which is the key active residue of DptE protein. By performing site-directed mutagenesis on the lysine residue at the 454th position, the three-dimensional structure of DptE protein can be precisely modified. This structural adjustment can finely regulate the biological function of DptE protein.
[0077] In this embodiment, the process of performing saturation point mutation on the post-modification site K454 is specifically as follows:
[0078] 1) Inoculate Streptomyces roseosporus on an R5 medium plate and perform preliminary culture in an incubator set at 30°C. After colonies are formed, pick a single colony of Streptomyces roseosporus from the R5 medium plate and inoculate it into TSB-MD liquid medium, and continue to culture at 30°C with shaking at 280 rpm for 48 hours. After the culture is completed, collect the mycelium of Streptomyces roseosporus in the culture medium, and extract the total genome of Streptomyces roseosporus from the mycelium of Streptomyces roseosporus;
[0079] 2) Design specific primers, use the genome of Streptomyces roseosporus as a template to amplify and recover the DptE protein encoding gene, obtain the DptE protein encoding gene fragment, and construct it into the Streptomyces integration expression vector pSET152;
[0080] Wherein, the base sequence of the DptE protein encoding gene fragment is shown in SEQ ID NO.1;
[0081] The specific primers include upstream amplification primers and downstream amplification primers of the DptE protein encoding gene, specifically:
[0082] The upstream amplification primer of the DptE protein encoding gene has a base sequence as shown in SEQ ID NO.19:
[0083] GATATCACATCGATCTCTAGAGTGAGTGAGAGCCGCT
[0084] The downstream amplification primers of the DptE protein encoding gene, the base sequence is shown in SEQ ID NO.20:
[0085] CGCCCCGCCGCCGCCGGATCCTCAGGTGCGGTCGGCC.
[0086] 3) using the DptE protein encoding gene fragment as a template, using PCR technology or other means familiar to those skilled in the art, introducing multiple amino acid mutations at position 454 of the DptE protein to obtain multiple DptE mutant protein encoding gene fragments having different amino acid sequences of DptE point mutant proteins;
[0087] The methods for introducing multiple amino acid mutations at position 454 of the DptE protein include: mutating the lysine at position 454 of the DptE protein to glycine (K454G), alanine (K454A), valine (K454V), leucine (K454L), isoleucine (K454I), proline (K454P), phenylalanine (K454F), tyrosine (K454Y), tryptophan (K454W), serine (K454S), threonine (K454T), cysteine (K454C), methionine (K454M), asparagine (K454N), glutamine (K454Q), aspartic acid (K454D), glutamic acid (K454E), arginine (K454R), and histidine (K454H).
[0088] By using genetic engineering methods such as conjugation transfer technology to introduce the DptE mutant protein encoding gene into Streptomyces roseosporus, it is possible to optimize and regulate key production performance such as the fermentation yield of the engineered strain. Next, in this embodiment, the DptE mutant protein encoding gene fragments and the DptE protein encoding gene fragments of each DptE point mutant protein obtained in step 3) are transferred to the dptE-deficient Streptomyces roseosporus ΔdptE constructed in step 4) of this embodiment by conjugation transfer technology, and multiple strains of dptE point mutant Streptomyces roseosporus are obtained.
[0089] The specific process of transferring each DptE point mutant protein encoding gene or DptE protein encoding gene to the dptE-deficient Streptomyces roseosporus to obtain the dptE mutant Streptomyces roseosporus is as follows:
[0090] 4) Knock out the DptE protein encoding gene (hereinafter referred to as dptE gene) from Streptomyces roseosporus to obtain dptE-deficient Streptomyces roseosporus ΔdptE. Specifically, the following steps are included:
[0091] 4.1) Using the genome of Streptomyces roseosporus as a template, design and use the upstream homology arm amplification primer pair and the downstream homology arm amplification primer pair of the DptE protein encoding gene to amplify the upstream homology arm and the downstream homology arm of the DptE protein encoding gene respectively and recover them to obtain the upstream homology arm and the downstream homology arm of the DptE protein encoding gene; the base sequences of the upstream homology arm amplification primer pair and the downstream homology arm amplification primer of the DptE protein encoding gene are:
[0092] Primer pair for amplifying the upstream homology arm of the dptE gene:
[0093] The first dptE upstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.11:
[0094] ACGACGGCCAGTGCCAAGCTTCACTCTGGGAGACGGTGGAA;
[0095] The second dptE upstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.12:
[0096] CGTTCACGAACTCGGTCTAGACGAGTTGCTGTCGGAGGGT;
[0097] Primer pair for amplifying the downstream homology arm of the dptE gene:
[0098] The first dptE downstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.13:
[0099] TCCGACAGCAACTCGTCTAGACCGAGTTCGTGAACGAGACA;
[0100] The second dptE downstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.14:
[0101] CATGATTACGAATTCGATATCG TGCCGTAGGAGTTGATGTGGA.
[0102] 4.2) The upstream homology arm and the downstream homology arm of the DptE protein encoding gene obtained in step 4.1) were constructed into the knockout vector pKC1139 to obtain the dptE gene knockout plasmid pKC1139-dptE-Knock-out and sequenced for verification;
[0103] 4.3) The dptE gene knockout plasmid pKC1139-dptE-Knock-out obtained in step 4.2) was introduced into E. coli ET12567 / pUZ8002 by chemical transformation technology to obtain E. coli ET12567 / pUZ8002 / pKC1139-ΔdptE;
[0104] 4.4) Transfer the E. coli ET12567 / pUZ8002 / pKC1139-ΔdptE obtained in step 4.3) into LB medium and culture at 30°C in a shaking incubator until OD 600=0.6, Escherichia coli E.coli ET12567 / pUZ8002 / pKC1139-ΔdptE was mixed with the mycelium of Streptomyces roseosporus, and the dptE gene knockout plasmid pKC1139-dptE-Knock-out obtained in step 4.2) was transferred into Streptomyces roseosporus by conjugation transduction technology; the dptE-deficient Streptomyces roseosporus with the DptE protein coding gene knocked out was screened to obtain the genotype of the strain ΔdptE, which was named Streptomyces roseosporus ΔdptE;
[0105] 5) inserting the coding gene fragment (DptE point mutant protein coding gene fragment or DptE protein coding gene fragment) into the expression vector pSET152 to obtain a dptE mutant plasmid carrying the coding gene fragment, and sequencing verification;
[0106] 6) introducing the dptE mutant plasmid obtained in step 5) into E. coli ET12567 / pUZ8002 by chemical transformation to obtain E. coli containing the dptE mutant plasmid;
[0107] The E. coli containing the dptE mutant plasmid was transferred to LB medium and cultured at 37°C and 280 rpm until the OD 600 =0.6, the Escherichia coli containing the dptE mutant plasmid was mixed with the dptE-deficient Streptomyces roseosporus ΔdptE, and then the Escherichia coli-Streptomyces interspecies transfer was performed, so that the dptE mutant plasmid was transferred into the dptE-deficient Streptomyces roseosporus ΔdptE, and the dptE mutant Streptomyces roseosporus carrying the coding gene fragment was obtained after screening.
[0108] In this embodiment, the obtained dptE mutant Streptomyces roseosporus includes Streptomyces roseosporus ΔdptE::dptE and Streptomyces roseosporus ΔdptE::dptE::K454*. Among them, the DptE protein encoding gene is transferred into Streptomyces roseosporus ΔdptE to obtain Streptomyces roseosporus ΔdptE::dptE, and the strain expresses DptE protein. The encoding gene of the DptE mutant protein DptE::K454* is transferred into Streptomyces roseosporus ΔdptE to obtain Streptomyces roseosporus ΔdptE::dptE::K454*, and the DptE mutant protein DptE::K454* is expressed.
[0109] Finally, in this example, each strain of dptE mutant Streptomyces roseosporus was used for the fermentation production of daptomycin, and the yield of daptomycin was detected. The process of using each strain of dptE mutant Streptomyces roseosporus to ferment and produce daptomycin and detect the yield of daptomycin is as follows:
[0110] 7) picking a single colony of the dptE mutant Streptomyces roseosporus and inoculating it into the primary seed culture medium (TSB-MD), and culturing it at 30° C. and 280 rpm for 2 days to obtain a first bacterial suspension;
[0111] 8) adding the first bacterial suspension obtained in step 7) to the secondary seed culture solution (TSB) at a volume ratio of 1 / 1000, and culturing at 30° C. and 280 rpm for 1 day to obtain a second bacterial suspension;
[0112] 9) adding the second bacterial suspension obtained in step 8) to the liquid fermentation medium (YEME) at a volume ratio of 1 / 1000, culturing at 30° C. and 280 rpm for 5 days, and adding the capric acid mixture dropwise at a ratio of 1‰ (V / V) every 12 hours from the 72nd hour after the start of the culture;
[0113] 10) On the 5th day after the start of the culture in step 9), 1 mL of the culture mixture was taken and centrifuged at 12000 rpm for 30 min. The supernatant was taken and mixed with methanol at a volume ratio of 1:1, and the yield of daptomycin was detected by HPLC. The detection conditions of HPLC detection are as follows:
[0114] Daptomycin was analyzed using an Agilent C18 reverse phase column (Zorbax300SB-C18, 5 μm, 4.6*250 mm) and a 1260 InfinityII high performance liquid chromatograph;
[0115] Liquid phase flow rate 1mL / min;
[0116] Dual UV detection wavelengths: 215nm and 254nm;
[0117] Column oven: 35°C;
[0118] Injection volume: 50 μL;
[0119] Mobile phase A was an aqueous solution containing 0.1% formic acid (V / V), and mobile phase B was acetonitrile;
[0120] Liquid phase working procedure: 0 minutes, A:B=90:10%; 5 minutes, A:B=65:35%; 55 minutes, A:B=45:55%; 60 minutes, A:B=5:95%; 63 minutes, A:B=90:10%; 65 minutes, A:B=90:10%.
[0121] The yield of daptomycin produced by fermentation of each dptE mutant Streptomyces roseosporus is as follows Figure 5 shown. Figure 5The daptomycin production data of each dptE mutant strain of Streptomyces roseosporus in YEME fermentation broth for 120 hours are shown in Figure 2. Among them, "dptE" represents Streptomyces roseosporus ΔdptE::dptE, and "dptE(K454*)" represents Streptomyces roseosporus ΔdptE::dptE::K454*.
[0122] It can be seen that Streptomyces roseosporus ΔdptE::dptE::K454I (17 mg / L) has the highest daptomycin production, and Streptomyces roseosporus ΔdptE::dptE::K454R (16 mg / L) also has a higher daptomycin production than Streptomyces roseosporus ΔdptE::dptE (14 mg / L). Therefore, the expression of DptE mutant protein DptE::K454I and DptE mutant protein DptE::K454R in the host bacteria is beneficial to improve the daptomycin production of the host bacteria ( Figure 5 ).
[0123] Example 2
[0124] This embodiment provides a DptE three-point mutant protein DptE::K454I::Q420N::K184Q based on the DptE protein mutated by K454I, Q420N and K184Q. Since the above-mentioned crotonylation site is at the entrance of the protein active cavity, another two residues (Q420, K184) are selected at the entrance to shorten, and the DptE protein mutant with a larger active pocket entrance is obtained by mutating the 420th glutamine of the DptE protein to asparagine and the 184th lysine to glutamine.
[0125] In this example, the gene encoding the DptE triple-point mutant protein was transferred into Streptomyces roseosporus ΔdptE using conjugation transfer technology to obtain Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q that can express the DptE triple-point mutant protein.
[0126] The construction process of Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q specifically includes the following steps:
[0127] 1) Using the DptE protein encoding gene fragment obtained in step 2) of Example 1 as a template, introducing mutations at positions 454, 420 and 184 of the DptE protein by means well known to those skilled in the art such as PCR, that is, mutating lysine at position 454 to isoleucine (K454I), glutamine at position 420 to asparagine (Q420N) and lysine at position 184 to glutamine (K184Q), respectively, to obtain a DptE triple-point mutant protein encoding gene;
[0128] 2) According to steps 5) to 6) in Example 1, the DptE triple-point mutant protein encoding gene was introduced into the Streptomyces roseosporus ΔdptE obtained in step 4) of Example 1 to obtain the dptE triple-point mutant Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q, which carries the DptE triple-point mutant protein encoding gene.
[0129] After the strain construction is completed, in this embodiment, according to steps 7) to 10) in Example 1, at different addition ratios of the decanoic acid mixture, daptomycin is produced by fermentation using Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q and Streptomyces roseosporus ΔdptE::dptE, Streptomyces roseosporus ΔdptE::dptE::K454I and Streptomyces roseosporus ΔdptE::dptE::K454R constructed in Example 1, and the daptomycin yield is detected after culturing in a liquid fermentation medium (YEME) for 5 days. Among them, the addition ratio of the decanoic acid mixture includes 1‰, 1.5‰ and 2‰ (V / V).
[0130] Figure 2 The daptomycin yield data of each strain in this example after culturing for 120 hours in a liquid fermentation medium (YEME) with different capric acid mixture addition ratios (1‰, 1.5‰, 2‰, V / V). It can be seen that compared with other mutant strains, Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q has a significantly higher daptomycin yield, and the yield is the highest when cultivated at a capric acid mixture addition ratio of 1.5‰ (V / V).
[0131] In addition, when comparing the yields of each strain at a decanoic acid mixture addition ratio of 1.5‰ (V / V), the yield of Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q was 132% higher than that of Streptomyces roseosporus ΔdptE::dptE. Therefore, the optimal decanoic acid mixture addition ratio for Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q was 1.5‰ (V / V).
[0132] In this embodiment, the utilization capacity of each strain for capric acid was also detected by HPGC. The process of implementing HPGC detection on the fermentation broth of each strain is specifically as follows:
[0133] 1) Under the condition that the decanoic acid mixture was added at a ratio of 2‰, daptomycin was fermented in a liquid fermentation medium (YEME) using Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q and Streptomyces roseosporus ΔdptE::dptE, respectively. After 78 h of cultivation, 1 mL of the fermentation broth of each of the two strains was taken as a test sample. After 82 h of cultivation, 1 mL of the fermentation broth of each of the two strains was taken as a test sample.
[0134] 2) Add 10 μL of perchloric acid to each bottle of test sample and vortex for 2 minutes; then add 1 mL of n-hexane and vortex for 5 minutes; centrifuge at 10000g for 10 minutes at room temperature, and draw the organic phase (upper liquid) for HPGC detection of decanoic acid residue. HPGC detection uses Agilent capillary column (HP-FFAP stationary phase, 30m*0.32mm*0.25μm, Agilent Technologies) and 7890A gas chromatograph; the injection port temperature is set to 270°C, the injection volume is 1 μL; use 1mL / min (N 2 ) with a constant flow rate of 5:1; the temperature program included: initially holding at 50°C for 4 minutes, then increasing to 150°C at a rate of 10°C / min and continuing for another 4 minutes; followed by detection using a FID detector with the detector temperature set to 28°C.
[0135] Figure 1 The results of HPGC test of the residual decanoic acid in the cells of Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q and Streptomyces roseosporus ΔdptE::dptE in liquid fermentation medium (YEME) at 78h and 84h. It can be seen that the residual decanoic acid in Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q is significantly lower than that in Streptomyces roseosporus ΔdptE::dptE, showing better decanoic acid utilization ability.
[0136] Example 3
[0137] In this embodiment, the TagR protein encoding gene (referred to as tagR gene) was further knocked out in Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q, and an engineered bacterium with higher decanoic acid tolerance was obtained than a strain in which the tagR gene was simply knocked out or a strain in which the mutant protein DptE::K454I::Q420N::K184Q was simply introduced. This is because the tagR gene is modified by DNA m4C methylation, and DNA methylation is usually related to the environmental stress response of the bacterium. Therefore, after knocking out the tagR gene, the decanoic acid tolerance of the bacterium is further improved.
[0138] This embodiment is completed by the following steps:
[0139] 1) designing and using an upstream homology arm amplification primer pair and a downstream homology arm amplification primer pair of a TagR protein encoding gene (tagR gene) to respectively amplify the upstream homology arm and the downstream homology arm of the TagR protein encoding gene and recover them to obtain the upstream homology arm and the downstream homology arm of the TagR protein encoding gene;
[0140] The base sequence of the TagR protein encoding gene is shown in SEQ ID NO.9; the amino acid sequence of the TagR protein is shown in SEQ ID NO.10. The base sequences of the upstream homology arm amplification primer pair and the downstream homology arm amplification primer pair of the TagR protein encoding gene are specifically:
[0141] Primer pair for amplifying the upstream homology arm of TagR protein encoding gene:
[0142] The first tagR upstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.15:
[0143] GGGCTGCAGGTCGACTCTAGAGCCCTTCTCGTTGATGCCG;
[0144] The second tagR upstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.16:
[0145] AGCCGCCAGTACAGCGGGTTCCCCGTTCGGTGGT;
[0146] Primer pair for amplifying the downstream homology arm of TagR protein encoding gene:
[0147] The first tagR downstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.17:
[0148] CGCTGTACTGGCGGCTCGTC;
[0149] The second tagR downstream homology arm amplification primer has a base sequence as shown in SEQ ID NO.18:
[0150] TGATTACGAATTCGATATCGCGGCTTTGCCTGGACTT.
[0151] 2) constructing the upstream homology arm and the downstream homology arm of the TagR protein encoding gene obtained in step 1) into the knockout vector pKC1139 to obtain the tagR gene knockout plasmid pKC1139-ΔtagR and verifying it;
[0152] 3) introducing the tagR gene knockout plasmid pKC1139-ΔtagR obtained in step 2) into E. coli ET12567 / pUZ8002 by chemical transformation to obtain E. coli containing the tagR gene knockout plasmid pKC1139-ΔtagR;
[0153] The knockout plasmid pKC1139-ΔtagR was transferred to Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q through interspecies conjugation transfer between Escherichia coli and Streptomyces, and the tagR gene-deficient colonies of the strain were screened and named Streptomyces roseosporus ΔtagR::ΔdptE::dptE::K454I::Q420N::K184Q, i.e., the engineered strain (Streptomyces roseosporus) delta-tagR::DptE3M, with a deposit number of CGMCCNO.31146. The knockout plasmid pKC1139-ΔtagR was transferred to Streptomyces roseosporus ΔdptE::dptE, and the tagR gene-deficient colonies of the strain were screened and named Streptomyces roseosporus ΔtagR::ΔdptE::dptE.
[0154] After the strain construction was completed, in this embodiment, according to steps 7) to 10) in Example 1, fermentation was carried out using Streptomyces roseosporus ΔtagR::ΔdptE::dptE::K454I::Q420N::K184Q, Streptomyces roseosporus ΔtagR::ΔdptE::dptE, Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q constructed in Example 2, and Streptomyces roseosporus ΔdptE::dptE constructed in Example 1, respectively, at different addition ratios of the capric acid mixture. In this embodiment, the addition ratio of the capric acid mixture includes 1‰, 1.5‰, 2‰, 3‰ and 4‰ (V / V).
[0155] During the cultivation process in the liquid fermentation medium (YEME), 1 mL of the culture mixture was taken from each bottle at 24h, 48h, 72h, 96h, 120h, and 144h of fermentation, and the supernatant was discarded after centrifugation at 12000rpm for 30min. The precipitated bacteria were placed in a 65°C oven and dried thoroughly, and then weighed to calculate the growth curve.
[0156] Figure 3The growth curve data of Streptomyces roseosporus ΔtagR::ΔdptE::dptE::K454I::Q420N::K184Q, Streptomyces roseosporus ΔtagR::ΔdptE::dptE, Streptomyces roseosporus ΔdptE::dptE::K454I::Q420N::K184Q and Streptomyces roseosporus ΔdptE::dptE under different addition ratios of decanoic acid mixture (1‰, 1.5‰, 2‰, 3‰ and 4‰ V / V). It can be seen that from the 72nd hour after the start of culture, after adding decanoic acid mixture with different volume fractions (1‰, 1.5‰, 2‰, 3‰ and 4‰ V / V) to the fermentation medium, the growth trend of the strain generally showed a downward trend. However, after the third addition of decanoic acid mixture (96th hour), the growth trend of the strain generally began to recover. After culturing for 144 hours, the strain growth density under different addition ratios of decanoic acid mixtures was compared. It can be seen that when a higher volume fraction (0.4%) and a lower volume fraction (0.1%) of decanoic acid mixtures were added, the strain density of Streptomyces roseosporus ΔtagR::ΔdptE::dptE::K454I::Q420N::K184Q was able to recover to a similar level. This phenomenon shows that the strain can still maintain a high growth recovery ability when facing decanoic acid concentrations under extreme conditions, and the strain has significantly higher decanoic acid tolerance than other strains. This adaptability to different decanoic acid volume fractions not only significantly improves the production efficiency of daptomycin, but also provides a strong guarantee for the utilization of raw materials and strain stability in the industrial fermentation process, which is conducive to further improving the yield of daptomycin through downstream technical means such as decanoic acid flow addition process development in industrial production.
[0157] The above specific implementation modes are used to explain the present invention rather than to limit the present invention. Any modification and change made to the present invention within the spirit of the present invention and the protection scope of the claims shall fall within the protection scope of the present invention.
[0158] The above description is only a preferred embodiment of the present invention, so all equivalent changes or modifications made according to the structure, characteristics and principles described in the scope of the patent application of the present invention are included in the scope of the patent application of the present invention.
Claims
1. A DptE mutant protein, characterized in that: The DptE mutant protein includes one of the DptE mutant protein DptE::K454I, the DptE mutant protein DptE::K454R and the DptE mutant protein DptE::K454I::Q420N::K184Q; the DptE mutant protein DptE::K454I is obtained by the mutation of lysine at position 454 of the DptE protein to isoleucine; the DptE mutant protein DptE::K454R is obtained by the mutation of lysine at position 454 of the DptE protein to arginine; the DptE mutant protein DptE::K454I::Q420N::K184Q is obtained by the mutation of lysine at position 454 of the DptE protein to isoleucine, the mutation of glutamine at position 420 to asparagine and the mutation of lysine at position 184 to glutamine.
2. A DptE mutant protein according to claim 1, characterized in that: The amino acid sequence of the DptE protein is shown in SEQ ID NO.2; the amino acid sequence of the DptE mutant protein DptE::K454I is shown in SEQ ID NO.4; the amino acid sequence of the DptE mutant protein DptE::K454R is shown in SEQ ID NO.6; the amino acid sequence of the DptE mutant protein DptE::K454I::Q420N::K184Q is shown in SEQ ID NO.
8.
3. A DptE mutant protein encoding gene for encoding the DptE mutant protein according to claim 1 or 2, characterized in that: The DptE mutant protein encoding gene includes one of the DptE mutant protein encoding gene K454I, the DptE mutant protein encoding gene K454R, and the DptE mutant protein encoding gene K454I::Q420N::K184Q; the DptE mutant protein encoding gene K454I is used to encode the DptE mutant protein DptE::K454I, and the base sequence is shown in SEQ ID NO.3; the DptE mutant protein encoding gene K454R is used to encode the DptE mutant protein DptE::K454R, and the base sequence is shown in SEQ IDNO.5; the DptE mutant protein encoding gene K454I::Q420N::K184Q is used to encode the DptE mutant protein DptE::K454I::Q420N::K184Q, and the base sequence is shown in SEQ ID NO.
7.
4. A high-capric acid-tolerant daptomycin high-yield engineered strain, characterized by: The engineering strain uses Streptomyces roseosporus as the starting strain, and the engineering strain is obtained by replacing the DptE protein encoding gene in the starting strain with the DptE mutant protein encoding gene as claimed in claim 3, and knocking out the TagR protein encoding gene.
5. The high-decanoic acid-tolerant daptomycin high-yield engineered strain according to claim 4, characterized in that: The base sequence of the TagR protein encoding gene is shown in SEQ ID NO.
9.
6. The high-decanoic acid-tolerant daptomycin high-yield engineered strain according to claim 4, characterized in that: The engineering strain is classified and named as Streptomyces roseosporus delta-tagR::DptE3M, and its deposit number is CGMCC NO.31146.
7. A method for constructing a daptomycin high-yield engineered strain as claimed in any one of claims 4 to 6, characterized in that: The construction method comprises the following steps: S1) using the genome of Streptomyces roseosporus as a template, amplifying the upstream homology arm and the downstream homology arm of the DptE protein encoding gene and constructing them into the knockout vector pKC1139 to obtain the dptE gene knockout plasmid pKC1139-dptE-Knock-out; The dptE gene knockout plasmid pKC1139-dptE-Knock-out was introduced into Streptomyces roseosporus using the E. coli-Streptomyces interspecies transfer technique mediated by E. coli ET12567 / pUZ8002 to obtain Streptomyces roseosporus ΔdptE; S2) using the genome of Streptomyces roseosporus as a template, amplifying a DptE protein encoding gene fragment, using the DptE protein encoding gene fragment as a template, introducing amino acid mutations using PCR technology to obtain a DptE mutant protein encoding gene fragment, and inserting the DptE mutant protein encoding gene fragment into the expression vector pSET152 to obtain a dptE mutant plasmid; Using the E. coli-Streptomyces interspecies conjugative transfer technique mediated by E. coli ET12567 / pUZ8002, the dptE mutant plasmid was introduced into Streptomyces roseosporus ΔdptE to obtain the dptE mutant Streptomyces roseosporus; S3) using the genome of Streptomyces roseosporus as a template, amplifying the upstream homology arm and the downstream homology arm of the TagR protein encoding gene and constructing them into the knockout vector pKC1139 to obtain the tagR gene knockout plasmid pKC1139-ΔtagR; The tagR gene knockout plasmid pKC1139-ΔtagR was introduced into the dptE mutant Streptomyces roseosporus using the E. coli-Streptomyces interspecies conjugative transfer technique mediated by E. coli ET12567 / pUZ8002 to obtain the engineered strain.
8. The construction method according to claim 7, characterized in that: In the step S2), the base sequence of the DptE protein encoding gene fragment is shown as SEQ ID NO.1; the base sequence of the DptE mutant protein encoding gene fragment is shown as SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7; in the step S3), the base sequence of the TagR protein encoding gene is shown as SEQ ID NO.
9.
9. Use of the DptE mutant protein according to claim 1 or 2, the DptE mutant protein encoding gene according to claim 3, the daptomycin high-yielding engineered strain according to any one of claims 4 to 6, or the engineered strain constructed by the construction method according to claim 7 or 8, characterized in that: Used for fermentation production of daptomycin.
10. A method for producing daptomycin, characterized in that: The following steps are involved: The daptomycin high-yield engineered strain according to any one of claims 4 to 6 or the daptomycin high-yield engineered strain constructed by the construction method according to claim 7 or 8 is cultured in a fermentation medium, and after culturing for 70 to 74 hours, the daptomycin high-yield engineered strain is cultured every 12 hours according to The capric acid mixture is added dropwise to the fermentation medium at a volume ratio of 1‰ to 4‰, and a fermentation product is obtained after the culture is completed. Fidaxomycin is isolated from the fermentation product.
Citation Information
Cited By
Regulatory gene for improving utilization rate and tolerance of capric acid in streptomyces roseosporus and application of regulatory gene
CN113717259A
Regulatory gene for improving utilization rate and tolerance of capric acid in streptomyces roseosporus and application thereof
CN113717259B
